Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

ARAY

Accuray (ARAY)

Accuray Incorporated
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ARAY
FechaHoraFuenteTítuloSímboloCompañía
10/05/202415:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARAYAccuray Incorporated
08/05/202415:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARAYAccuray Incorporated
01/05/202415:06PR Newswire (US)Accuray Reports Fiscal 2024 Third Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
25/04/202406:35PR Newswire (US)Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024NASDAQ:ARAYAccuray Incorporated
18/04/202406:35PR Newswire (US)Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, SwitzerlandNASDAQ:ARAYAccuray Incorporated
17/04/202415:05PR Newswire (US)Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024NASDAQ:ARAYAccuray Incorporated
26/03/202406:35PR Newswire (US)New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® SystemNASDAQ:ARAYAccuray Incorporated
05/03/202415:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARAYAccuray Incorporated
04/03/202415:30PR Newswire (US)Accuray Incorporated to Speak at 36th Annual Roth ConferenceNASDAQ:ARAYAccuray Incorporated
27/02/202416:30PR Newswire (US)Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNASDAQ:ARAYAccuray Incorporated
13/02/202410:19Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ARAYAccuray Incorporated
13/02/202406:35PR Newswire (US)Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® SystemNASDAQ:ARAYAccuray Incorporated
05/02/202416:30PR Newswire (US)Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:ARAYAccuray Incorporated
31/01/202415:06PR Newswire (US)Accuray Reports Fiscal 2024 Second Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
25/01/202406:35PR Newswire (US)Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 SessionsNASDAQ:ARAYAccuray Incorporated
16/01/202416:30PR Newswire (US)Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024NASDAQ:ARAYAccuray Incorporated
05/12/202306:30PR Newswire (US)Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® SystemNASDAQ:ARAYAccuray Incorporated
30/11/202315:01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ARAYAccuray Incorporated
07/11/202315:07PR Newswire (US)Accuray Reports Fiscal 2024 First Quarter Financial ResultsNASDAQ:ARAYAccuray Incorporated
31/10/202306:30PR Newswire (US)Accuray to Participate in the 14th Annual Jefferies London Healthcare ConferenceNASDAQ:ARAYAccuray Incorporated
26/10/202315:05PR Newswire (US)Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023NASDAQ:ARAYAccuray Incorporated
03/10/202315:05PR Newswire (US)Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products AdministrationNASDAQ:ARAYAccuray Incorporated
02/10/202306:35PR Newswire (US)Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual MeetingNASDAQ:ARAYAccuray Incorporated
29/09/202315:11Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ARAYAccuray Incorporated
29/09/202315:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARAYAccuray Incorporated
29/09/202315:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ARAYAccuray Incorporated
18/09/202306:35PR Newswire (US)Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer CareNASDAQ:ARAYAccuray Incorporated
14/09/202306:30PR Newswire (US)Accuray to Host Investor Day at ASTRO on October 3, 2023NASDAQ:ARAYAccuray Incorporated
07/09/202315:56Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARAYAccuray Incorporated
09/08/202319:00PR Newswire (US)Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU MarketNASDAQ:ARAYAccuray Incorporated
 Showing the most relevant articles for your search:NASDAQ:ARAY

Su Consulta Reciente

Delayed Upgrade Clock